CAH gains from a solid pharmaceutical segment and a diversified product portfolio. However, regulatory setbacks are a concern.

SYK continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio.

EQR's strategy of targeting affluent renters and portfolio diversification are upsides. However, an elevated supply of rental units is a concern.

EQR's strategy of targeting affluent renters and portfolio diversification are upsides. However, an elevated supply of rental units is a concern.

QDEL's strong product portfolio raises optimism about the stock.

RVTY's strong product portfolio raises optimism about the stock.

FMS continues to gain traction through its broad dialysis product and service portfolio. Ongoing macro challenges raise concerns.

WELL's seniors housing operating portfolio is set to benefit from the aging population and rising healthcare spending. However, high competition is a...

WELL's seniors housing operating portfolio is set to benefit from the aging population and rising healthcare spending. However, high competition is a...

AXON is set to benefit from solid momentum across its segments. However, increasing costs and expenses remain a concern.